MetLife Insiders Plan $82K Stock Sale as Investment Funds Reduce Holdings

MetLife has filed a Form 144 notice for the proposed sale of 1,024 shares of common stock with an aggregate market value of $81,879.04.

Rhea-AI Filing Summary

MetLife has filed a Form 144 notice for the proposed sale of 1,024 shares of common stock with an aggregate market value of $81,879.04. The sale is planned to be executed through Goldman Sachs on the NYSE, with an approximate sale date of June 27, 2025.

The securities to be sold were acquired in three separate purchases during 2013:

• 31 shares from Deutsche Bank on January 31, 2013
• 902 shares from Goldman Sachs on March 13, 2013
• 91 shares from Goldman Sachs on May 15, 2013

Recent trading activity shows that related entities have sold 1,256 shares in the past three months, totaling approximately $99,076.70 in gross proceeds. The filing was made by the MetLife 401(k) Plan Trust, which maintains an affiliate discretionary manager relationship with the issuer. The company has 671,297,826 shares outstanding.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many MET shares are being sold according to the June 2025 Form 144 filing?

According to the Form 144 filing, 1,024 shares of MetLife (MET) common stock are proposed to be sold through Goldman Sachs, with an aggregate market value of $81,879.04. The sale is expected to take place on the NYSE around June 27, 2025.

Who is selling MET shares in this Form 144 filing?

The MetLife 401(k) Plan Trust is selling the shares, acting as an affiliate discretionary manager. The filing was signed by Mirsad Usejnoski and the shares will be sold through Goldman Sachs at 200 West Street, New York.

What recent MET stock sales were disclosed in the three months prior to this Form 144?

In the three months prior to this filing, there were several sales of MET stock: 221 shares by Separate Account II on 6/13/2025, and on 6/20/2025: 547 shares by MetLife 401k Plan Trust, 360 shares by Separate Account SPI, 101 shares by Separate Account II, and 27 shares by Separate Account 149, totaling 1,256 shares.

When were the MET shares being sold originally acquired?

The shares being sold were acquired in three separate purchases in early 2013: 31 shares from Deutsche Bank on January 31, 2013, 902 shares from Goldman Sachs on March 13, 2013, and 91 shares from Goldman Sachs on May 15, 2013. All purchases were made with cash payment.

What is the total number of MET shares outstanding as of June 2025?

According to the Form 144 filing, MetLife (MET) had 671,297,826 shares outstanding at the time of the filing in June 2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/27/2025 - 03:13 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002027739
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	METLIFE INC
SEC File Number	001-15787
Address of Issuer	200 Park Avenue New York NEW YORK 10016
Phone	212-578-2211
Name of Person for Whose Account the Securities are To Be Sold	MetLife 401(k) Plan Trust
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Affiliate discretionary manager

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Goldman Sachs 200 West Street New York NY 10005	1024	81879.04	671297826	06/27/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	01/31/2013	Purchase	DEUTSCHE BANK			31	02/05/2013	Cash
Common Stock	03/13/2013	Purchase	Goldman Sachs			902	03/18/2013	Cash
Common Stock	05/15/2013	Purchase	Goldman Sachs			91	05/20/2013	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Separate Account II 1 Metlife Way Whippany NJ 07981	Common Stock	06/13/2025	221	17094.35
MetLife 401k Plan Trust 1 Metlife Way Whippany NJ 07981	Common Stock	06/20/2025	547	43327.87
Separate Account SPI 1 Metlife Way Whippany NJ 07981	Common Stock	06/20/2025	360	28515.6
Separate Account II 1 Metlife Way Whippany NJ 07981	Common Stock	06/20/2025	101	8000.21
Separate Account 149 1 Metlife Way Whippany NJ 07981	Common Stock	06/20/2025	27	2138.67

144: Remarks and Signature

Remarks
Date of Notice	06/27/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Mirsad Usejnoski
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)